Get started
Author

Yan Sun

Observed name: Y.Z. Sun
ORCID: 0000-0001-8706-3669
Observed ORCID: 0000-0001-8706-3669
OpenAlex ID: A5090765795
Extraction and separation of In(III), Ga(III) and Zn(II) from sulfate solution using extraction resin
2006 · J.S. Liu, H. Chen, et al. · Hydrometallurgy · 101
ELN Risk Stratification Is Not Predictive of Outcomes for Treatment-Naïve Patients with Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine
2022 · Hartmut Döhner, Keith W. Pratz, et al. · Blood · 84
Assessing Physical Stability of Colloidal Dispersions Using a Turbiscan Optical Analyzer
2019 · Yan Sun, Alexandru Deac, et al. · Molecular Pharmaceutics · 69
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study
2022 · Naveen Pemmaraju, Jacqueline S Garcia, et al. · The Lancet Haematology · 59
Simultaneous extraction and recovery of gold(I) from alkaline solutions using an environmentally benign polymer inclusion membrane with ionic liquid as the carrier
2019 · Ziyue Wang, Yan Sun, et al. · Separation and Purification Technology · 54
Efficient extraction of gold(I) from alkaline aurocyanide solution using green ionic liquid-based aqueous biphasic systems
2018 · Xiangjun Yang, Changlin Miao, et al. · Journal of the Taiwan Institute of Chemical Engineers · 37
Chemotactic responses of the root-knot nematode Meloidogyne incognita to Streptomyces plicatus
2019 · Pinyi Wang, Yan Sun, et al. · FEMS Microbiology Letters · 31
Improved transport of gold(I) from aurocyanide solution using a green ionic liquid-based polymer inclusion membrane with in-situ electrodeposition
2019 · Yan Sun, Ziyue Wang, et al. · Process Safety and Environmental Protection · 30
Equilibrium and mechanism studies of gold(I) extraction from alkaline aurocyanide solution by using fluorine‐free ionic liquids
2020 · Ya‐Ting Wang, Men Liu, et al. · Rare Metals · 23
Distribution Behavior of Amino Acid by Extraction with Di(2-ethylhexyl) Phosphoric Acid
1997 · Qing-Hong Shi, Yan Sun, et al. · Separation Science and Technology · 18
The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification
2022 · Francesco Passamonti, James M. Foran, et al. · Blood · 15
Multi-Omic Single-Cell Sequencing Reveals Genetic and Immunophenotypic Clonal Selection in Patients With FLT3-Mutated AML Treated With Gilteritinib/Venetoclax
2022 · Vanessa E. Kennedy, Cheryl Peretz, et al. · Blood · 5
Impact of moisture and plasticizer properties on polymer–plasticizer physical mixing performance
2014 · Raimundo Ho, Yan Sun, et al. · Journal of Applied Polymer Science · 5
RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance
2025 · Vanessa E. Kennedy, Cheryl A. C. Peretz, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
Abstract 2530: DELE1 loss and dysfunctional integrated stress signaling in TP53 mutated AML is a novel pathway for venetoclax resistance
2023 · David Sharon, Paul Jung, et al. · Cancer Research · 2
Measurable residual disease in Japanese patients with relapsed or refractory chronic lymphocytic leukemia treated with venetoclax
2023 · Koji Izutsu, Kazuhito Yamamoto, et al. · International Journal of Hematology · 1
PDF
Abstract LB108: Addition of navitoclax to ruxolitinib mediates responses suggestive of disease modification in patients with myelofibrosis previously treated with ruxolitinib monotherapy
2022 · Naveen Pemmaraju, Jacqueline Garcia, et al. · Cancer Research · 1
P418: Dele1 Loss and Dysfunctional Integrated Stress Signaling in Tp53 Mutated Aml Is a Novel Pathway for Venetoclax Resistance
2023 · David Sharon, Paul Jung, et al. · HemaSphere
Works count: 18
Citation count: 539
H-index: 11
I10-index: 11
Year
Topic
Type